Huang YH, Liu FT, Wan CL, Wang ZJ, et al. Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysis. Leuk Lymphoma 2025 Oct 6:1-11. doi: 10.1080/10428194.2025.2566317.
PMID: 41048093